Keller Eric L.
- SEC CIK
- 0002156365
In the past year, 1 open-market purchase filing worth $249.6K and no sales.
Current role at each company
- RTSNRetension Pharmaceuticals, Inc.CHIEF EXECUTIVE OFFICERas of Oct 13, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $249.6K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$249.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Keller Eric L. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 2026 (view filing)6:12 PM ET | Oct 13 | Same day | Keller Eric L.CHIEF EXECUTIVE OFFICER | PPurchase | +20.8K | $12.00 | +$249.6K | +5.2%423.4K after |